MedTrace Logo

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

NCT04670874 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1250

Last updated 2026-01-28

No results posted yet for this study

Summary

This study assesses the quality of life in patients with cutaneous lymphoma diagnosis as it relates to their personal, clinical, and therapeutic information using the Skindex29 questionnaire and also assesses patients' understanding of their diagnosis and need for resources related to their care. Cutaneous lymphomas are a rare type of blood cancers (non-Hodgkin lymphoma) that present in the skin. The information gained from this study, may help researchers improve quality of life in cutaneous lymphoma patients.

Conditions

  • Cutaneous Lymphoma

Interventions

OTHER

Quality-of-Life Assessment

Complete quality of life questionnaire

OTHER

Questionnaire Administration

Complete quality of life questionnaire

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Christiane Querfeld · City of Hope Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-17
Primary Completion
2034-01-24
Completion
2034-01-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04670874 on ClinicalTrials.gov